DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Pipe S, Shima M, Lehle M. , et al.
A multicentre, open-label, phase 3 study to evaluate the efficacy, safety, and pharmacokinetics of emicizumab prophylaxis administered every 4 weeks in persons with haemophilia A.
Lancet Haematol 2019;
DOI: https://doi.org/10.1016/S2352-3026(19)30054-7.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.